AU Stock MarketDetailed Quotes

Paradigm Biopharmaceuticals Ltd (PAR)

Watchlist
  • 0.160
  • -0.010-5.88%
20min DelayMarket Closed May 1 16:00 AET
72.28MMarket Cap-2.67P/E (Static)

Paradigm Biopharmaceuticals Ltd (PAR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2025
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
(FY)Jun 30, 2018
(FY)Jun 30, 2017
(FY)Jun 30, 2016
Total revenue
-20.79%52.12K
40.72%65.8K
-40.98%46.76K
285.52%79.22K
20.55K
Operating revenue
-20.79%52.12K
40.72%65.8K
-40.98%46.76K
285.52%79.22K
--20.55K
----
----
----
----
----
Cost of revenue
129.09%20.59K
-52.26%8.99K
-86.90%18.83K
45.00%143.75K
99.14K
Gross profit
-44.50%31.53K
103.39%56.81K
143.29%27.93K
17.89%-64.53K
-78.59K
Operating expense
-64.03%23.47M
8.63%65.25M
25.33%60.07M
10.65%47.93M
152.21%43.31M
67.98%17.17M
14.33%10.22M
45.61%8.94M
42.12%6.14M
4.32M
Selling and administrative expenses
-15.11%5.28M
-5.31%6.22M
-17.26%6.56M
-9.30%7.93M
109.96%8.75M
79.71%4.17M
-0.58%2.32M
23.30%2.33M
30.39%1.89M
--1.45M
-General and administrative expense
-15.11%5.28M
-5.31%6.22M
-17.26%6.56M
-9.30%7.93M
109.96%8.75M
79.71%4.17M
-0.58%2.32M
23.30%2.33M
30.39%1.89M
--1.45M
Research and development costs
-69.59%17.74M
10.73%58.33M
35.03%52.68M
16.39%39.01M
161.98%33.52M
62.01%12.79M
19.75%7.9M
55.79%6.59M
47.59%4.23M
--2.87M
Depreciation amortization depletion
3.19%151.42K
--146.74K
----
-70.98%60.97K
-1.44%210.06K
2,452.92%213.12K
-45.62%8.35K
-7.67%15.35K
555.90%16.63K
--2.54K
-Depreciation and amortization
3.19%151.42K
--146.74K
----
-70.98%60.97K
-1.44%210.06K
2,452.92%213.12K
-45.62%8.35K
-7.67%15.35K
555.90%16.63K
--2.54K
Other operating expenses
-45.21%303.3K
-32.71%553.61K
-10.47%822.7K
9.80%918.86K
--836.88K
----
----
----
----
----
Operating profit
64.04%-23.44M
-8.59%-65.19M
-25.10%-60.04M
-10.60%-47.99M
-152.66%-43.39M
-67.98%-17.17M
-14.33%-10.22M
-45.61%-8.94M
-42.12%-6.14M
-4.32M
Net non-operating interest income (expenses)
-10.77%350.36K
-71.67%392.64K
5,897.84%1.39M
-86.52%23.11K
-82.21%171.4K
268.15%963.48K
385.56%261.71K
110.37%53.9K
-75.26%25.62K
103.57K
Non-operating interest income
-12.18%357.44K
-70.98%407.01K
2,610.61%1.4M
-75.26%51.74K
-79.04%209.13K
281.20%997.65K
385.56%261.71K
110.37%53.9K
-75.26%25.62K
--103.57K
Non-operating interest expense
-50.72%7.08K
-12.46%14.37K
-42.67%16.42K
-24.09%28.63K
10.40%37.72K
--34.17K
----
----
----
----
Other net income (expenses)
-30.53%4.17M
-11.00%6M
-22.12%6.74M
-0.63%8.66M
135.60%8.71M
165.17%3.7M
-311.52%-5.67M
47.12%2.68M
41.28%1.82M
1.29M
Special income (charges)
---2.53M
----
----
----
----
----
---6.93M
----
----
----
-Less:Impairment of capital assets
--2.53M
----
----
----
----
----
--6.93M
----
----
----
Other non-operating income (expenses)
11.68%6.7M
-11.00%6M
-22.12%6.74M
-0.63%8.66M
135.60%8.71M
194.66%3.7M
-53.22%1.25M
47.12%2.68M
41.28%1.82M
--1.29M
Income before tax
68.00%-18.77M
-12.99%-58.65M
-32.26%-51.91M
-14.44%-39.25M
-178.86%-34.3M
21.30%-12.3M
-152.45%-15.63M
-44.79%-6.19M
-46.20%-4.28M
-2.92M
Income tax
0
0
0
0
0
0
0
0
0
0
Earnings from equity interest net of tax
Net income
68.00%-18.77M
-12.99%-58.65M
-32.26%-51.91M
-14.44%-39.25M
-178.86%-34.3M
21.30%-12.3M
-152.45%-15.63M
-44.79%-6.19M
-46.20%-4.28M
-2.92M
Net income continuous operations
68.00%-18.77M
-12.99%-58.65M
-32.26%-51.91M
-14.44%-39.25M
-178.86%-34.3M
21.30%-12.3M
-152.45%-15.63M
-44.79%-6.19M
-46.20%-4.28M
---2.92M
Noncontrolling interests
Net income attributable to the company
68.00%-18.77M
-12.99%-58.65M
-32.26%-51.91M
-14.44%-39.25M
-178.86%-34.3M
21.30%-12.3M
-152.45%-15.63M
-44.79%-6.19M
-46.20%-4.28M
-2.92M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
68.00%-18.77M
-12.99%-58.65M
-32.26%-51.91M
-14.44%-39.25M
-178.86%-34.3M
21.30%-12.3M
-152.45%-15.63M
-44.79%-6.19M
-46.20%-4.28M
-2.92M
Diluted earnings per share
70.15%-0.0597
-11.63%-0.2
-9.98%-0.1792
-0.78%-0.1629
-173.53%-0.1616
44.01%-0.0591
-104.98%-0.1055
-22.15%-0.0515
-24.17%-0.0422
-0.0339
Basic earnings per share
70.15%-0.0597
-11.63%-0.2
-9.98%-0.1792
-0.78%-0.1629
-173.53%-0.1616
44.01%-0.0591
-104.98%-0.1055
-22.15%-0.0515
-24.17%-0.0422
-0.0339
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2025(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019(FY)Jun 30, 2018(FY)Jun 30, 2017(FY)Jun 30, 2016
Total revenue -20.79%52.12K40.72%65.8K-40.98%46.76K285.52%79.22K20.55K
Operating revenue -20.79%52.12K40.72%65.8K-40.98%46.76K285.52%79.22K--20.55K--------------------
Cost of revenue 129.09%20.59K-52.26%8.99K-86.90%18.83K45.00%143.75K99.14K
Gross profit -44.50%31.53K103.39%56.81K143.29%27.93K17.89%-64.53K-78.59K
Operating expense -64.03%23.47M8.63%65.25M25.33%60.07M10.65%47.93M152.21%43.31M67.98%17.17M14.33%10.22M45.61%8.94M42.12%6.14M4.32M
Selling and administrative expenses -15.11%5.28M-5.31%6.22M-17.26%6.56M-9.30%7.93M109.96%8.75M79.71%4.17M-0.58%2.32M23.30%2.33M30.39%1.89M--1.45M
-General and administrative expense -15.11%5.28M-5.31%6.22M-17.26%6.56M-9.30%7.93M109.96%8.75M79.71%4.17M-0.58%2.32M23.30%2.33M30.39%1.89M--1.45M
Research and development costs -69.59%17.74M10.73%58.33M35.03%52.68M16.39%39.01M161.98%33.52M62.01%12.79M19.75%7.9M55.79%6.59M47.59%4.23M--2.87M
Depreciation amortization depletion 3.19%151.42K--146.74K-----70.98%60.97K-1.44%210.06K2,452.92%213.12K-45.62%8.35K-7.67%15.35K555.90%16.63K--2.54K
-Depreciation and amortization 3.19%151.42K--146.74K-----70.98%60.97K-1.44%210.06K2,452.92%213.12K-45.62%8.35K-7.67%15.35K555.90%16.63K--2.54K
Other operating expenses -45.21%303.3K-32.71%553.61K-10.47%822.7K9.80%918.86K--836.88K--------------------
Operating profit 64.04%-23.44M-8.59%-65.19M-25.10%-60.04M-10.60%-47.99M-152.66%-43.39M-67.98%-17.17M-14.33%-10.22M-45.61%-8.94M-42.12%-6.14M-4.32M
Net non-operating interest income (expenses) -10.77%350.36K-71.67%392.64K5,897.84%1.39M-86.52%23.11K-82.21%171.4K268.15%963.48K385.56%261.71K110.37%53.9K-75.26%25.62K103.57K
Non-operating interest income -12.18%357.44K-70.98%407.01K2,610.61%1.4M-75.26%51.74K-79.04%209.13K281.20%997.65K385.56%261.71K110.37%53.9K-75.26%25.62K--103.57K
Non-operating interest expense -50.72%7.08K-12.46%14.37K-42.67%16.42K-24.09%28.63K10.40%37.72K--34.17K----------------
Other net income (expenses) -30.53%4.17M-11.00%6M-22.12%6.74M-0.63%8.66M135.60%8.71M165.17%3.7M-311.52%-5.67M47.12%2.68M41.28%1.82M1.29M
Special income (charges) ---2.53M-----------------------6.93M------------
-Less:Impairment of capital assets --2.53M----------------------6.93M------------
Other non-operating income (expenses) 11.68%6.7M-11.00%6M-22.12%6.74M-0.63%8.66M135.60%8.71M194.66%3.7M-53.22%1.25M47.12%2.68M41.28%1.82M--1.29M
Income before tax 68.00%-18.77M-12.99%-58.65M-32.26%-51.91M-14.44%-39.25M-178.86%-34.3M21.30%-12.3M-152.45%-15.63M-44.79%-6.19M-46.20%-4.28M-2.92M
Income tax 0000000000
Earnings from equity interest net of tax
Net income 68.00%-18.77M-12.99%-58.65M-32.26%-51.91M-14.44%-39.25M-178.86%-34.3M21.30%-12.3M-152.45%-15.63M-44.79%-6.19M-46.20%-4.28M-2.92M
Net income continuous operations 68.00%-18.77M-12.99%-58.65M-32.26%-51.91M-14.44%-39.25M-178.86%-34.3M21.30%-12.3M-152.45%-15.63M-44.79%-6.19M-46.20%-4.28M---2.92M
Noncontrolling interests
Net income attributable to the company 68.00%-18.77M-12.99%-58.65M-32.26%-51.91M-14.44%-39.25M-178.86%-34.3M21.30%-12.3M-152.45%-15.63M-44.79%-6.19M-46.20%-4.28M-2.92M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 68.00%-18.77M-12.99%-58.65M-32.26%-51.91M-14.44%-39.25M-178.86%-34.3M21.30%-12.3M-152.45%-15.63M-44.79%-6.19M-46.20%-4.28M-2.92M
Diluted earnings per share 70.15%-0.0597-11.63%-0.2-9.98%-0.1792-0.78%-0.1629-173.53%-0.161644.01%-0.0591-104.98%-0.1055-22.15%-0.0515-24.17%-0.0422-0.0339
Basic earnings per share 70.15%-0.0597-11.63%-0.2-9.98%-0.1792-0.78%-0.1629-173.53%-0.161644.01%-0.0591-104.98%-0.1055-22.15%-0.0515-24.17%-0.0422-0.0339
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More